"[...] The trial for severe-to-critical Covid-19 patients, which costs about $9 million, has recruited 247 of its targeted 390 patients, Pourhassan said. The FDA has agreed to review its efficacy results at the 75% recruitment point, which could be hit as soon as next week, Seethamraju said. [...]"

NP says enrollment is at 247 (63%) and Dr. SMJ thinks it could reach 75% (293 patients) next week. Although enrollment has increased to nearly 1 patient per day (or more by now), the enrollment of 46 over a week is not realistic. Maybe the author misquoted Dr. SMJ or less likely, enrollment at the time of this quote had increased exponentially. I don’t have access to the article because it requires a subscription, so I’m unable to read the article and make a judgement on legitimacy.